Fertility Services Global Market To Reach Value Of About $28 Billion In 2025

The fertility services market consists of sales of infertility treatment services and related products by entities (organizations, sole traders and partnerships) that provide infertility treatment services which are used in various applications to treat infertile patients. Fertility treatment is a medical procedure intended to increase the chances of conceiving a child. Only goods and services traded between entities or sold to end consumers are included

Global Fertility Services Market Size And Drivers:

The global fertility services market is expected to grow from $16.95 billion in 2020 to $18.48 billion in 2021 at a compound annual growth rate (CAGR) of 9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $28.24 billion in 2025 at a CAGR of 11%. Growing infertility rates are anticipated to boost the demand for fertility services during the forecast period.

Request For A Sample For The Global Fertility Services Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3371&type=smp

Trends In The Global Fertility Services Market

Companies in the fertility services market have witnessed significant growth in the number of research collaborations as well as research funding approvals. Key companies operating in the market are projected to increase their R&D expenditure to introduce new advanced techniques and drugs used for fertility treatments. For instance, in June 2019, Thermo Fisher Scientific announced a research collaboration with Predictive Laboratories, a wholly-owned subsidiary of Predictive Technology Group, Inc., concentrating on studying the genetic factors causing infertility in women. The collaboration is expected to utilize Thermo Fisher Scientific's offerings for reproductive health including Ion ReproSeq PGS Assay, Applied Biosystems CarrierScan Assay, Ion AmpliSeq Exome RDY for whole-exome sequencing, and CytoScan Dx Assay. Furthermore, in March 2019, Olympus Corporation, a Japan-based company, announced a collaboration with the Jikei University School of Medicine to develop AI-assisted sperm selection, which aims to reduce the workload in intracytoplasmic sperm injection (ICSI). The research is expected to help embryologists to select good sperm.

Global Fertility Services Market Segments:
The global fertility services market is further segmented –
By Procedure: Assisted Reproductive Technology (ART), In-Vitro Fertilization, Artificial Insemination
By Service: Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor
By Application: Male, Female
By Geography: The global fertility services market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Fertility Services Market At:

Fertility Services Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides fertility services market overviews, analyzes and forecasts market size and growth for the global fertility services market, fertility services market share, fertility services market players, fertility services market segments and geographies, fertility services market’s leading competitors’ revenues, profiles and market shares. The fertility services market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.